The exact contribution of thrombin to increased VEGF expression in COVID-19 is difficult to estimate, since VEGF production may also be driven by ARDS-associated hypoxia or inflammatory cytokines, and the intensity of these stimuli may change over the course of disease [74]. The gene discussed is VEGFA; the disease is acute respiratory distress syndrome.